Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats

Cite this paper

@inproceedings{Gowda2013TreatmentWC, title={Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats}, author={Nagesh Gowda and Anilkumar M Dandu and Jaideep Singh and Sanghamitra Biswas and Vijaya Raghav and Mudigere N Lakshmi and Pavagada C Shilpa and Venkategowda Sunil and Ashok Kumar Reddy and Manoj Kumar Sadasivuni and K. H. Aparna and Mahesh Kumar Verma and Yogananda Moolemath and Mammen O Anup and Marikunte V. Venkataranganna and Baggavalli P Somesh and Madanahalli R Jagannath}, booktitle={BMC Pharmacology and Toxicology}, year={2013} }